This position is being filled under a stream-lined hiring authority, Title 21 of the United States Code (21 US Code 379d-3a) as amended by the 21st Century Cures Act of 2016, section 3072 and the Consolidated Appropriations Act of 2023, Section 3624. The candidate selected for this position will serve under a career or career-conditional appointment and be paid under the provisions of this authority. This position is being recruited based on the Title 21 Pay Table 1, Band B (GS-12 equivalent). The analyst will independently conduct comprehensive disclosure analysis of complex, sensitive, and high-volume scientific and regulatory records involving FDA-regulated products, programs, research, inspections, submissions, applications, scientific reviews, clinical or laboratory information, and related agency records. This involves integrating professional scientific knowledge with regulatory context to determine whether individual passages, data elements, analyses, methods, findings, and related information are releasable, subject to protection, or require consultation. The role also evaluates how disclosure of one portion of a record may reveal protected information contained elsewhere in the record or submission. The analyst will apply FOIA exemptions and other disclosure restrictions to scientifically dense records, including questions involving confidential commercial information, trade secrets, personal privacy, pre-decisional or deliberative information, investigatory or enforcement-sensitive information, and information protected by specific statutes. The position makes independent proposed releasability determinations within delegated parameters; prepares redacted/releasable records; ensures segregability; and develops complete documentation supporting release, withholding, referral, and consultation decisions. Disclosure analyses are conducted for proactive publication, advisory committee materials, scientific-information sharing with domestic or international counterparts, and other authorized disclosure activities, adapting the review to the governing disclosure mechanism. Quality assurance and quality control methods are applied to determine risk and compliance standards for work and associated risk mitigation actions are implemented. The role develops well-supported recommendations for denials or partial denials and prepares scientific and factual analyses that allow authorized denial officials and counsel to evaluate the basis for withholding. The analyst analyzes changes in disclosure statutes, regulations, judicial decisions, Department of Justice guidance, or FDA policy and assesses their effect on established scientific-disclosure practices. Inconsistencies or gaps in existing disclosure practice are identified, and recommendations for clarifications, decision rules, or procedural changes are made to promote uniform treatment of comparable scientific information. The position serves as a scientific-disclosure consultant to FDA program offices, coordinating with scientists, physicians, engineers, reviewers, compliance personnel, product specialists, records custodians, and managers to resolve difficult questions concerning the scientific meaning and releasability of information. Disclosure consultations and referrals are coordinated with other FDA components, HHS, other Federal agencies, and information submitters when necessary to establish the factual basis for a disclosure decision. Standard operating procedures, job aids, decision matrices, scientific-disclosure examples, training materials, or reference resources are developed or substantially revised based on changes in law, policy, scientific practice, or recurring case issues. Training courses are conducted for Center staff on FOIA, Privacy Act, and implementing regulations, providing appropriate written instructions and guidelines.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level